Lilly powers ahead with plant investment even as it cuts 3,500 jobs

23rd October 2017 Uncategorised 0

Even as pricing pressure on its diabetes portfolio has led Eli Lilly to cut 3,500 jobs by year-end, the drugmaker today said it is moving forward with a $72 million upgrade to its insulin manufacturing, part of an $850 million outlay it had expected to make this year on capital projects.

More: Lilly powers ahead with plant investment even as it cuts 3,500 jobs
Source: fierce